Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SO vs GSK✓SelectedUSD · GSKSO vs GSK performance historyLatest closeAs of+1.95%11/16
Stock and ETF performance explorer

SO vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+82.8%
GSK return
+46.9%
Excess return
+35.9%
Maximum drawdown
-23.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.9%-0.1%+2.0%+2.0%
7D+2.0%-1.3%+3.3%+2.2%
30D+4.6%+2.7%+1.9%+4.0%
3M+3.7%+2.7%+1.0%+2.9%
6M+4.8%+3.3%+1.5%+3.9%
YTD+12.1%+6.5%+5.6%+10.0%
1Y+8.7%+10.7%-2.0%+5.7%
3Y+50.6%+64.4%-13.8%+31.6%
5Y+82.8%+46.7%+36.1%+56.3%
All+82.8%+46.9%+35.9%+56.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling